Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program

Autor: Jungblut, Lisa, von Garnier, Christophe, Puhan, Milo, Tomonaga, Yuki, Kaufmann, Cornel, Azzola, Andrea, Bürgi, Urs, Bremerich, Jens, Brutsche, Martin, Christe, Andreas, Ebner, Lukas, Heverhagen, Johannes T, Eich, Christine, Franzen, Daniel, Schmitt-Opitz, Isabelle, Schneiter, Didier, Spieldenner, Jörg, Horwarth, Nigel, Kohler, Malcolm, Weder, Walter, Lovis, Alban, Meuli, Reto, Menig, Matthias, Beigelmann-Aubry, Catherine, Niemann, Tilo, Stöhr, Susanna, Vock, Peter, Senn, Oliver, Neuner-Jehle, Stefan, Selby, Kevin, Laures, Simin, Ott, Sebastian, Frauenfelder, Thomas

Publikováno v: Swiss medical weekly, vol. 152, no. 15-16, pp. w30154
Jungblut, Lisa; von Garnier, Christophe; Puhan, Milo; Tomonaga, Yuki; Kaufmann, Cornel; Azzola, Andrea; Bürgi, Urs; Bremerich, Jens; Brutsche, Martin; Christe, Andreas; Ebner, Lukas; Heverhagen, Johannes T; Eich, Christine; Franzen, Daniel; Schmitt-Opitz, Isabelle; Schneiter, Didier; Spieldenner, Jörg; Horwath, Nigel; Kohler, Malcolm; Weder, Walter; ... (2022). The Swiss Approach-feasibility of a national low-dose CT lung cancer screening program. Swiss medical weekly, 152(15-16) EMH Media 10.4414/smw.2022.w30154

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths in Switzerland. Despite this, there is no lung cancer screening program in the country. In the United States, low-dose computed tomography (LDCT) lung cancer screening is partially

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9fc1ce656f18e4ddc485bd1c616e04
https://pubmed.ncbi.nlm.nih.gov/35633633

Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry

Autor: Appenzeller, Paula, Lichtblau, Mona, Berlier, Charlotte, Aubert, John-David, Azzola, Andrea, Fellrath, Jean-Marc, Geiser, Thomas, Lador, Frederic, Pohle, Susanne, Opitz, Isabelle, Schwerzmann, Markus, Stricker, Hans, Tamm, Michael, Saxer, Stéphanie, Ulrich, Silvia

Publikováno v: Pulm Circ
Appenzeller, Paula; Lichtblau, Mona; Berlier, Charlotte; Aubert, John-David; Azzola, Andrea; Fellrath, Jean-Marc; Geiser, Thomas; Lador, Frederic; Pohle, Susanne; Opitz, Isabelle; Schwerzmann, Markus; Stricker, Hans; Tamm, Michael; Saxer, Stéphanie; Ulrich, Silvia (2022). Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry. Pulmonary circulation, 12(1), e12001. Sage 10.1002/pul2.12001

Pulmonary hypertension (PH), especially pulmonary arterial and chronic thromboembolic pulmonary hypertension (PAH/CTEPH), are rare and progressive conditions. Despite recent advances in treatment and prognosis, PH is still associated with impaired qu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44291109b2c1a99a331e1af608365a36
https://pubmed.ncbi.nlm.nih.gov/35506112

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 3: Figure S2. of Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study

Autor: Joerg Salomon, Stolz, Daiana, Domenighetti, Guido, Jean-Georges Frey, Turk, Alexander, Azzola, Andrea, Sigrist, Thomas, Jean-William Fitting, Schmidt, Ulrich, Geiser, Thomas, Wild, Corinne, Kostikas, Konstantinos, Clemens, Andreas, Brutsche, Martin

Forced expiratory volume in 1 s (FEV1) [L] – pooled analysis of SYNERGY, SHINE and GLOW6 (N = 1503). (PDF 371 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f9fe523d59aea456af8a4f2c6ca1e64c